Box score
PolyPid Ltd.
Reported $35M sold in a new Form D filed January 22, 2024 (Petach Tikva, outside the US).
- Biggest raise
- $35M filed Jan 22, 2024
- League
- Bio & Health Biotechnology
- Based in
- Petach Tikva, outside the US
- Season rank
- #148 of 1,389 in the Bio & Health League; #569 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 4
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-06-23 | New notice | $26.7M | $26.7M | SEC |
| 2025-01-02 | New notice | $14.5M | $14.5M | SEC |
| 2024-08-12 | New notice | $14.2M | $14.2M | SEC |
| 2024-01-22 | New notice | $35M | $35M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1611842.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Establishment Labs Holdings Inc. | Bio & Health | $50M |
| 2 | Radiant Biotherapeutics Inc. rookie | Bio & Health | $34.3M |
| 3 | Brainsway Ltd. rookie | Bio & Health | $20M |
| 4 | CASI Pharmaceuticals, Inc. rookie | Bio & Health | $15M |
| 5 | Spry Therapeutics Inc. rookie | Bio & Health | $15M |
| 6 | Medicenna Therapeutics Corp. | Bio & Health | $14.6M |